NCT06957964 Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial
| NCT ID | NCT06957964 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr Hamail Khanum |
| Condition | Wound |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2025-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-03-25 with a primary completion date of 2025-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total 70 participants meeting selection criteria will be enrolled in the study from operational theatre. They will be randomly divided in two groups by using lottery method. In group A, Negative Pressure Wound Therapy will be applied at end of procedure. In group B, no Negative Pressure Wound Therapy will be placed. They will be shifted to post-surgical wad for 72 hours and then will be discharged with prescription of standard antibiotics and will be followed-up in OPD for 30 days. If patient will develop surgical site wound infection, then it will be noted. If infection will not be cured with antibiotics course, then re-operation will be done. Patients complications will be managed as per hospital protocol. All this information will be recorded in proforma.
Eligibility Criteria
Inclusion Criteria: * Patients of age between 20 to 70 years, both genders * Undergoing laparotomy under general anaesthesia * ASA I-II Exclusion Criteria: * Patients who did not complete the follow up instructions * Pregnant patients * Patients already undergone a relook laparotomy, if their abdomen is left open or if unable to adhere
Contact & Investigator
Professor Dr Maratab Ali, MBBS FCPS
STUDY DIRECTOR
Gulab Devi Hospital
Frequently Asked Questions
Who can join the NCT06957964 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Wound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06957964 currently recruiting?
Yes, NCT06957964 is actively recruiting participants. Contact the research team at hamailkhanum@gmail.com for enrollment information.
Where is the NCT06957964 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06957964 clinical trial?
NCT06957964 is sponsored by Dr Hamail Khanum. The principal investigator is Professor Dr Maratab Ali, MBBS FCPS at Gulab Devi Hospital. The trial plans to enroll 70 participants.